In an agreement to resolve a multitude of consumer lawsuits, AstraZeneca Pharmaceuticals will pay $425 million. The plaintiffs, approximately 11,000 in number, claimed to have suffered kidney injuries subsequent to their use of the drugs Nexium and Prilosec. This settlement, unveiled on Tuesday, makes it the largest to date in the multidistrict litigation centered around proton-pump inhibitor medications. These medications are commonly used to manage heartburn and stomach acid related complications.
Notably, AstraZeneca isn’t the only pharmaceutical company embroiled in such disputes. Other firms, including GlaxoSmithKline, Procter & Gamble, and Pfizer, have also reached previous settlements totaling $108.5 million in this ongoing multidistrict litigation. The settlement of AstraZeneca, however, surpasses those combined, symbolizing the large scale of this particular litigation.
Details surrounding this development are still unfolding in the legal sector, and professionals are paying close attention to how this may shape the pharmaceutical realm. More information can be found here.